Overexpression of LLGL2 was linked to aggressive clinicopathological characteristics consisting of tumor number, vascular infiltration as well as advanced stage, and it was one of the independent risk indicators of OS and DFS in HCC. This evidence concerns the gene LLGL2 and hepatocellular carcinoma.